PATHOGENETIC ASPECTS OF STATINS’ APPLICABILITY IN COMBINATION TREATMENT OF PATIENTS WITH UTERINE FIBROIDS AND EXTRAGENITAL PATHOLOGIES
Clinical medicine

PATHOGENETIC ASPECTS OF STATINS’ APPLICABILITY IN COMBINATION TREATMENT OF PATIENTS WITH UTERINE FIBROIDS AND EXTRAGENITAL PATHOLOGIES

Published 2017-08-29

Authors:

V.M. Zhurakivskyi

Abstract:
The article involves materials of thesis research conducted in accordance with the plan of SHEE «Ivano-Frankivsk national medical university» and is a part of academic research work of the department of obstetrics and gynecology named after I.D. Lanovyi “Clinical and medico-social grounding of effective methods for the prediction of pathologic states, diagnosis and treatment of women during pregnancy and other periods of their life” (state registration number 0104U008431).
Keywords:
hyperplastic processes of the uterus lipid metabolism sex hormones statins
References:
  1. Csatlós E. Uterine leiomyoma / E. Csatlós, J. Jr. Rigó, I. Szabó [et al.] // Orv. Hetil. – 2010. – Vol. 151, № 42. – P. 1734–1741.
  2. Ezem B. U. Krukenberg tumour simulating uterine fibroids and pelvic inflammatory disease / B. U. Ezem, C. C. Osuagwu, I. V. Onyiaorah // Niger. J. Clin. Pract. – 2010. – Vol. 13, № 3. – P. 336–337.
  3. Kuricheva N. Yu. Differentiated approach to the treatment of endometrial hyperplastic processes in women in the perimenopausal period / N. Yu. Kuricheva // Medytsyna siohodni i zavtra . – 2010. – № 1. – P. 28–32.
  4. Lethaby A. Fibroids (uterine myomatosis, leiomyomas) / A.Lethaby, B.Vollenhoven // Clin. Evid. – 2011.– Vol. 41,№ 12. – P. 83–89.
  5. Munro M. G. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age / M. G. Munro, H. O. Critchley, M. S. Broder [et al.] // Int. J. Gynaecol. Obstet. – 2011. – Vol. 113, № 1. – P. 3–13.
  6. Scheurig-Muenkler C. Uterine artery embolization for symptomatic fibroids: long-term changes in disease-specific symptoms and quality of life / C. Scheurig-Muenkler, A. Lembcke, V. Froeling [et al.] // Hum. Reprod. – 2011. – Vol. 23, № 7. – P 74–79.
  7. Tanfin Z. Endothelin-1: physiological and pathological roles in myometrium / Z. Tanfin, D. Leiber, P. Robin [et al.] // Int. J. Biochem. Cell. Biol. – 2011. – Vol. 43, № 3. – P. 299–302.
  8. Tsuiji K. Inhibitory effect of curcumin on uterine leiomyoma cell proliferation / K. Tsuiji, T. Takeda, B. Li [et al.] // Gynecol. Endocrinol. – 2011. – Vol. 27, № 7. – P. 512–517.
  9. Wei L. H. Histone Deacetylase 6 Regulates Estrogen Receptor {alpha} in Uterine Leiomyoma / L. H. Wei, P. L. Torng, S. M. Hsiao [et al.] // Reprod Sci. – 2011. – Vol. 3, № 6. – P. 432–437.
  10. Ventskivska I. B. Differential treatment of endometrial hyperplastic processes against the background of internal endometriosis / I. B. Ventskivska , L.P. Kuzmiuk // Zdorovie zhenshchiny. – 2010. – № 9. – P. 129–131.
  11. Voogt M. J. Uterine Fibroid Embolisation for Symptomatic Uterine Fibroids: A Survey of Clinical Practice in Europe / M. J. Voogt, M. J. Arntz, P. N. Lohle [et al.] // Cardiovasc. Intervent. Radiol. – 2010. – Vol. 29, № 12. – P. 395–399.
Publication:
«World of Medicine and Biology» Vol. 13 No. 61 (2017) , с. 22-26
УДК 618.14 – 089 + 618.14 + 618.14-006